Rapid and sensitive intraoperative detection of mutations in the isocitrate dehydrogenase 1 and 2 genes during surgery for glioma
- PMID: 24745708
- DOI: 10.3171/2014.3.JNS131505
Rapid and sensitive intraoperative detection of mutations in the isocitrate dehydrogenase 1 and 2 genes during surgery for glioma
Abstract
Object: Intraoperative diagnosis is important in determining the strategies during surgery for glioma. Because the mutations in the isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) genes have diagnostic, prognostic, and predictive values, the authors assessed the feasibility and significance of a simplified method for the intraoperative detection of IDH1 and IDH2 gene mutations.
Methods: Rapid DNA extraction, amplification with conventional polymerase chain reaction (PCR) or co-amplification at lower denaturation temperature PCR (COLD-PCR), and fluorescence melting curve analysis with adjacent hybridization probes were performed for the intraoperative detection of IDH1 and IDH2 mutations in 18 cases of suspected nonneoplastic lesions and low- and high-grade gliomas and in 3 cases of radiation necrosis.
Results: DNA extraction for detection of the mutation took 60-65 minutes. The results of this assay showed complete correlation with that of Sanger sequencing. The sensitivity for detection of mutations in a background of wild-type genes was 12.5% and 2.5% in conventional PCR and COLD-PCR, respectively. The diagnosis of glioma was established in 3 of 5 cases in which definitive diagnosis was not obtained using frozen sections, and information was obtained for the discrimination of glioblastoma or glioblastoma with an oligodendroglioma component from anaplastic glioma or secondary glioblastoma. This assay also detected a small fraction of tumor cells with IDH1 mutation in radiation necrosis.
Conclusions: These methods provide important information for establishing the differential diagnosis between low-grade glioma and nonneoplastic lesions and the diagnosis for subtypes of high-grade glioma. Although tumor cells in radiation necrosis were detected with a high sensitivity, further investigation is necessary for clinical application in surgery for recurrent glioma.
Keywords: COLD = co-amplification at lower denaturation temperature; FMCA = fluorescence melting curve analysis; IDH = isocitrate dehydrogenase; IDH1; IDH2; PCR = polymerase chain reaction; Tc = denaturation temperature; Tm = melting temperature; glioma; intraoperative molecular diagnosis; oncology.
Similar articles
-
A new sensitive PCR assay for one-step detection of 12 IDH1/2 mutations in glioma.Acta Neuropathol Commun. 2014 Jun 2;2:58. doi: 10.1186/2051-5960-2-58. Acta Neuropathol Commun. 2014. PMID: 24889502 Free PMC article.
-
A novel COLD-PCR/FMCA assay enhances the detection of low-abundance IDH1 mutations in gliomas.Diagn Mol Pathol. 2013 Mar;22(1):28-34. doi: 10.1097/PDM.0b013e31826c7ff8. Diagn Mol Pathol. 2013. PMID: 23370430
-
Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization-mass spectrometry.J Neurosurg. 2019 Jan 4;132(1):180-187. doi: 10.3171/2018.8.JNS181207. Print 2020 Jan 1. J Neurosurg. 2019. PMID: 30611146
-
Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.Neurosurg Focus. 2015 Mar;38(3):E2. doi: 10.3171/2015.1.FOCUS14745. Neurosurg Focus. 2015. PMID: 25727224 Review.
-
Isocitrate dehydrogenase 1 and 2 mutations in gliomas.J Neurosci Res. 2014 Dec;92(12):1611-20. doi: 10.1002/jnr.23456. Epub 2014 Jul 31. J Neurosci Res. 2014. PMID: 25078896 Review.
Cited by
-
Future directions of operative neuro-oncology.J Neurooncol. 2016 Nov;130(2):377-382. doi: 10.1007/s11060-016-2180-3. Epub 2016 Jun 22. J Neurooncol. 2016. PMID: 27334902 Review.
-
Ultra-early stage lower-grade gliomas: How can we define and differentiate these easily misdiagnosed gliomas through intraoperative molecular diagnosis.CNS Neurosci Ther. 2024 Oct;30(10):e70044. doi: 10.1111/cns.70044. CNS Neurosci Ther. 2024. PMID: 39385311 Free PMC article.
-
Role of molecular biomarkers in glioma resection: a systematic review.Chin Neurosurg J. 2020 May 18;6:18. doi: 10.1186/s41016-020-00198-x. eCollection 2020. Chin Neurosurg J. 2020. PMID: 32922947 Free PMC article. Review.
-
Rapid Intraoperative Molecular Characterization of Glioma.JAMA Oncol. 2015 Aug;1(5):662-7. doi: 10.1001/jamaoncol.2015.0917. JAMA Oncol. 2015. PMID: 26181761 Free PMC article.
-
IDH1 Mutation and World Health Organization 2016 Diagnostic Criteria for Adult Diffuse Gliomas: Advances in Surgical Strategy.Neurosurgery. 2017 Sep 1;64(CN_suppl_1):134-138. doi: 10.1093/neuros/nyx247. Neurosurgery. 2017. PMID: 28899049 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous